Mike Hoerger, PhD MSCR MBA Profile picture
Director of the top public U.S. #COVID forecasting dashboard (PMC). #HealthPsych PhD Program Director, #CovidCancer scientist, over 100 science publications.

Nov 13, 2022, 13 tweets

New article in @JAMANetworkOpen provides critical data on the long-term trajectory of COVID-19 symptoms.

Lots of bad news. 😕
Very bad news for ppl w/cancer or bad acute case of COVID. 😬
Also, a few rays of hope. 🌞
#LongCOVID #COVIDcancer

1/12
jamanetwork.com/journals/jaman…

66% of adults had at least 1 symptom during the acute phase (first 2 months) of diagnosis of #COVID-19.

I’ve highlighted the symptoms experienced by at least 10%. Note that some of the less common symptoms are quite debilitating though (e.g., 9% w/lung pain).

2/12

If you had a #COVID symptom initially, what are the chances it persists beyond 2 months? See 2nd column, green highlights emphasize those enduring among >10%.

Many of the initial symptoms endure in about 20% of ppl. Russian-roulette like odds.

3/12

If you know someone with a new #COVID infection/reinfection who is experiencing symptoms, dive deep into that particular row.

For example, while memory loss is rare (4.3%), it’s the most enduring symptom beyond 2 months (40% persisting).

4/12

If you had an acute #COVID symptom, what were the chances it would resolve within 1 year?
See authors’ BLACK text.

I’ve also added a column with the chances a symptom persists (ORANGE text). Balanced framing. 🙂

5/12

Now, let’s manually combine the acute (<2 month), near-term (>2 month), and long-term (>1yr) #COVID data into one figure. Silly JAMA. 😊

Some symptoms present at 2 months largely fall off. Others persist in >25% (palp, art pain, att/conc, memory, sleep).

6/12

Overall, the number of #COVID-19 symptoms each person experiences diminishes over time.

Caveats: Initial infections were all pre-vax (call for hope), but also pre-omicron and before many reinfections (call for caution). Note, %s are among those who had an acute symptom.

7/12

Older adults, women, and ppl w/>5 acute symptoms were more likely to have persistent #COVID symptoms at 1 year.

A history of #cancer predicted prolonged symptoms. #COVIDcancer

Higher BMI = more persistent symptoms. Bad for the U.S.

8/12

An Appendix figure models the typical time to resolution of a #COVID symptom (crude estimate, varies by symptom & individual).

I added the blue line, which suggest about 5% would experience symptoms at 3 yrs. That's >16 million Americans. Very rough estimate. #recession

9/12

Model of time to COVID-19 symptom resolution by subgroup.

#COVID has persistent effects for those with a history of cancer or who had a bad acute case. Either we have a critical gender health disparity or men are trying to walk off heart palpitations. 🤔

#COVIDcancer
10/12

An average of 10% of adults were experiencing long-term symptoms from #COVID-19.

The authors note that this is a critical public health problem b/c of the high incidence of infection. They are perhaps too optimistic. We have a high incidence of REinfections.

11/12

Limitations: The COVID-19 initial infections were all before the vaccine era, mostly before reinfections, and pre-omicron.

You cannot have long-term data AND up-to-date world events. Stay cautious until the long-term data are optimistic.

12/12

By the way, feel free to share any of this on other platforms (Mastodon, Discord, TikTok, Myspace, or even Facebook) and with family/friends. I tried to annotate the figures in a way that it would be relatable to a general audience. Where I failed, ask questions.

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling